References
- CunninghamDAtkinWLenzHJColorectal cancerLancet201037597191030104720304247
- OsumiHShinozakiESuenagaMRAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomyInt J Cancer2016139480381127004837
- VogelsteinBKinzlerKWCancer genes and the pathways they controlNat Med200410878979915286780
- SridharanMHubbardJMGrotheyAColorectal cancer: how emerging molecular understanding affects treatment decisionsOncology (Williston Park)201428211011824701697
- YangJCAhnMJKimDWOsimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA Study Phase II Extension ComponentJ Clin Oncol201735121288129628221867
- MokTSWuYLAhnMJOsimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancerN Engl J Med2017376762964027959700
- MayorSOsimertinib effective in EGFR T790M-positive lung cancerLancet Oncol2017181e927989430
- YuJZhangLNo PUMA, no death: implications for p53-dependent apoptosisCancer Cell20034424824914585351
- YuJWangZKinzlerKWVogelsteinBZhangLPUMA mediates the apoptotic response to p53 in colorectal cancer cellsProc Natl Acad Sci U S A200310041931193612574499
- PengRTongJSLiHTargeting bax interaction sites reveals that only homo-oligomerization sites are essential for its activationCell Death Differ201320574475423392123
- MingLSakaidaTYueWJhaAZhangLYuJSp1 and p73 activate PUMA following serum starvationCarcinogenesis200829101878188418579560
- YuJZhangLPUMA, a potent killer with or without p53Oncogene200827 Suppl 1S71S8319641508
- WangPQiuWDudgeonCPUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosisCell Death Differ20091691192120219444283
- SunJSunQBrownMFThe multi-targeted kinase inhibitor sunitinib induces apoptosis in colon cancer cells via PUMAPLoS One201278e4315822912816
- ZhaoZWangJTangJJNK- and Akt-mediated puma expression in the apoptosis of cisplatin-resistant ovarian cancer cellsBiochem J2012444229130122394200
- SunJKnickelbeinKHeKAurora kinase inhibition induces PUMA via NF-kappaB to kill colon cancer cellsMol Cancer Ther20141351298130824563542
- MingLWangPBankAYuJZhangLPUMA dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cellsJ Biol Chem200628123160341604216608847
- XieRChengMLiMAkt isoforms differentially protect against stroke-induced neuronal injury by regulating mTOR activitiesJ Cereb Blood Flow Metab201333121875188523942361
- TongJTanSZouFYuJZhangLFBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradationOncogene201736678779627399335
- MisaleSBozicITongJVertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancersNat Commun20156830526392303
- BergMSoreideKEGFR and downstream genetic alterations in KRAS/BRAF and PI3K/AKT pathways in colorectal cancer: implications for targeted therapyDiscov Med2012147620721423021375
- YorkERVarella-GarciaMBangTJAisnerDLCamidgeDRTolerable and effective combination of full dose crizotinib and osimertinib targeting MET amplification sequentially emerging after T790M positivity in EGFR mutant non-small cell lung cancerJ Thorac Oncol2017127e85e8828274743
- TanimotoATakeuchiSAraiSHistone deacetylase 3 inhibition overcomes BIM deletion polymorphism-mediated osimertinib-resistance in EGFR-mutant lung cancerClin Cancer Res201723123139314927986747
- SullivanIPlanchardDOsimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experienceTher Adv Respir Dis201610654956527784815
- Ni ChonghaileTSarosiekKAVoTTPretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapyScience201133460591129113322033517
- MisaleSYaegerRHoborSEmergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature2012486740453253622722830